on 09 Jan 2024
Last Applicant/ Owned by
1718 Ringwood Avenue
San Jose
CA
951311711
Serial Number
90980667 filed on 12th Oct 2020
Registration Number
7270464 registered on 09th Jan 2024
Correspondent Address
Bret E. Field
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, Read More
Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical products, namely, analgesics
13th Nov 2023
13th Nov 2023
No 90980667
No Service/Collective Mark
No TEIK-T030US2
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
09th Jan 2024 | REGISTERED-PRINCIPAL REGISTER |
09th Jan 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
08th Dec 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
07th Dec 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
01st Dec 2023 | DIVISIONAL PROCESSING COMPLETE |
01st Dec 2023 | STATEMENT OF USE PROCESSING COMPLETE |
29th Nov 2023 | DIVISIONAL REQUEST RECEIVED |
27th Nov 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
14th Nov 2023 | TEAS STATEMENT OF USE RECEIVED |
14th Nov 2023 | TEAS REQUEST TO DIVIDE RECEIVED |